Moderate coding emphasis
Architect roles typically involve less hands-on coding but still require solid algorithmic thinking for design trade-offs.
1 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Architect interviews focus heavily on system design, architectural patterns, and technical leadership scenarios.. Explore key insights and preparation tips to help you excel in your interview process.
Architect roles typically involve less hands-on coding but still require solid algorithmic thinking for design trade-offs.
System design is the primary evaluation criteria for architect candidates, covering scalability, reliability, and architectural patterns.
Distributed Systems
Microservices, event-driven architecture
Scalability Patterns
Load balancing, caching, sharding
Cloud Architecture
AWS/Azure/GCP design patterns
Different companies emphasize various architectural competencies based on their scale and technology stack.
Meta
Large-scale distributed systems and performance optimization
Stripe
Financial system reliability and API design patterns
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers 68% lower housing costs than San Francisco, with median home prices around $200K versus $1.2M+ in the Bay Area. Your architect salary stretches significantly further while maintaining access to major East Coast markets and prestigious projects.
Baltimore's architect job market shows 28% saturation versus 71% in San Francisco. Growing waterfront development and urban renewal projects create opportunities with manageable competition.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States